Pfizer drops hemophilia candidate collaboration with US biotech company

US-based Sangamo Therapies will certainly currently seek a brand-new course onward for the prospective genetics treatment giroctocogene fitelparvovec to deal with grownups with reasonably serious to serious hemophilia A.

发布者:BY CHRISTOPHER DUE KARLSSON,转转请注明出处:https://robotalks.cn/pfizer-drops-hemophilia-candidate-collaboration-with-us-biotech-company/

(0)
上一篇 3 1 月, 2025 3:18 上午
下一篇 3 1 月, 2025 3:18 上午

相关推荐

发表回复

您的邮箱地址不会被公开。 必填项已用 * 标注

联系我们

400-800-8888

在线咨询: QQ交谈

邮件:admin@example.com

工作时间:周一至周五,9:30-18:30,节假日休息

关注微信
社群的价值在于通过分享与互动,让想法产生更多想法,创新激发更多创新。